SCHEMBL1542763

SCHEMBL1542763

COc1c(NC(=O)c2ccc(O)cc2F)cc(-c2ccc[nH]c2=O)cc1C(=O)CC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 2/20 0.42
CYP3A4 P08684 3/20 0.36
ESRRG P62508 1/20 0.36
BTK Q06187 2/20 0.35
NTRK1 P04629 1/20 0.35
SCN10A Q9Y5Y9 4/20 0.34
SCN8A Q9UQD0 3/20 0.34
ABL1 P00519 1/20 0.34
TP53 P04637 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
ACLY P53396 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
ABCB1 P08183 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1543054 0.87 CYP3A4 (0.44) CD274CYP3A4ESRRGBTKNTRK1
SCHEMBL1542476 0.78 CYP3A4 (0.44) CD274CYP3A4BTKNTRK1SCN10A
SCHEMBL2127612 0.74 CYP3A4 (0.58) CD274CYP3A4BTKSCN10ASCN8A
SCHEMBL1542564 0.70 CYP3A4 (0.43) CD274CYP3A4BTKSCN10ASCN8A
SCHEMBL1543460 0.69 CYP3A4 (0.44) CD274CYP3A4BTKABL1TP53
SCHEMBL2127468 0.69 CYP3A4 (0.44) CD274CYP3A4ACLYKDM4EALDH1A1
SCHEMBL1542657 0.69 CYP3A4 (0.49) CYP3A4BTKABL1TP53KDM4E
SCHEMBL1542355 0.68 CYP3A4 (0.43) CD274CYP3A4BTKABL1KDM4E
SCHEMBL2128285 0.68 KDM4E (0.49) CD274CYP3A4BTKKDM4EALDH1A1
SCHEMBL1542759 0.67 CD274 (0.47) CD274CYP3A4BTKTP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307372-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2011-04-13 EP disclosed
WO-2010010017-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-01-28 WO disclosed